Progressive Encephalomyelitis With Rigidity and Myoclonus: The First Pediatric Case With Glycine Receptor Antibodies
IMPORTANCE Progressive encephalomyelitis with rigidity and myoclonus is characterized by rigidity, painful muscle spasms, hyperekplexia, and brainstem signs. Recently, glycine receptor alpha 1 antibodies have been described in adult patients with progressive encephalomyelitis with rigidity and myocl...
Gespeichert in:
Veröffentlicht in: | JAMA neurology 2013-04, Vol.70 (4), p.1-4 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 4 |
---|---|
container_issue | 4 |
container_start_page | 1 |
container_title | JAMA neurology |
container_volume | 70 |
creator | Damásio, Joana Leite, M. Isabel Coutinho, Ester Waters, Patrick Woodhall, Mark Santos, Manuela A Carrilho, Inês Vincent, Angela |
description | IMPORTANCE Progressive encephalomyelitis with rigidity and myoclonus is characterized by rigidity, painful muscle spasms, hyperekplexia, and brainstem signs. Recently, glycine receptor alpha 1 antibodies have been described in adult patients with progressive encephalomyelitis with rigidity and myoclonus. We describe a pediatric case. OBSERVATIONS A 14-month-old child developed startle-induced episodes of generalized rigidity and myoclonus, axial hyperextension, and trismus, without impairment of consciousness. Episodes occurred during wakefulness and sleep, lasted seconds, and were accompanied by moaning, tachypnea, and oxygen desaturation. Imaging, cerebrospinal fluid, endocrine, metabolic, and genetic screening findings were normal or negative. She was treated with intravenous steroids and immunoglobulins with resolution of symptoms, but she relapsed weeks later. At this time, episodes were more severe. Glycine receptor alpha 1 antibodies were found in serum (titer of 1:200, later 1:320) and cerebrospinal fluid (titer of 1:2). Treatment was restarted with intravenous steroids and immunoglobulins, with major improvement, and she began treatment with oral steroids. She had 4 milder relapses, with improvement after treatment adjustments. CONCLUSIONS AND RELEVANCE To our knowledge, this is the first pediatric case of progressive encephalomyelitis with rigidity and myoclonus associated with glycine receptor alpha 1 antibodies, a potentially severe but treatable antibody-mediated neurological disorder. |
doi_str_mv | 10.1001/jamaneurol.2013.1872 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1325331449</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><ama_id>1566613</ama_id><sourcerecordid>1325331449</sourcerecordid><originalsourceid>FETCH-LOGICAL-a275t-b142c8eb27be5428337ca60e855a73bf75d84b4114eb2ab6807622c86b6afe253</originalsourceid><addsrcrecordid>eNpFkE1LwzAch4MoTua-gIjk6GUzb00zbzI2FRRFJh5L0v7nIm0zk1Totzdjc-aSHJ7nF3gQuqRkQgmhN1-60S103tUTRiifUJWzI3TGqFRjSbP8-PAW0wEahfBF0lGECC5O0YBxrohS4gzFV-8-PYRgfwDP2xI2a127pofaRhvwh41r_GY_bWVjj3Vb4efelbVru3CLl2vAC-tDxK9QWR29LfFMB9hZ93Vf2hbwG6TR6Dy-a6M1rrIQztHJStcBRvt7iN4X8-XsYfz0cv84u3saa5ZncWyoYKUCw3IDmWCK87zUkoDKMp1zs8qzSgkjKBWJ0UYqkkuWDGmkXgHL-BBd73Y33n13EGLR2FBCXad2rgsF5QniVIhpQsUOLb0LwcOq2HjbaN8XlBTb5MV_8mKbvNgmT9rV_ofONFAdpL_ACbjYAcn-n8yklJTzX3F8iR8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1325331449</pqid></control><display><type>article</type><title>Progressive Encephalomyelitis With Rigidity and Myoclonus: The First Pediatric Case With Glycine Receptor Antibodies</title><source>MEDLINE</source><source>American Medical Association Journals</source><creator>Damásio, Joana ; Leite, M. Isabel ; Coutinho, Ester ; Waters, Patrick ; Woodhall, Mark ; Santos, Manuela A ; Carrilho, Inês ; Vincent, Angela</creator><creatorcontrib>Damásio, Joana ; Leite, M. Isabel ; Coutinho, Ester ; Waters, Patrick ; Woodhall, Mark ; Santos, Manuela A ; Carrilho, Inês ; Vincent, Angela</creatorcontrib><description>IMPORTANCE Progressive encephalomyelitis with rigidity and myoclonus is characterized by rigidity, painful muscle spasms, hyperekplexia, and brainstem signs. Recently, glycine receptor alpha 1 antibodies have been described in adult patients with progressive encephalomyelitis with rigidity and myoclonus. We describe a pediatric case. OBSERVATIONS A 14-month-old child developed startle-induced episodes of generalized rigidity and myoclonus, axial hyperextension, and trismus, without impairment of consciousness. Episodes occurred during wakefulness and sleep, lasted seconds, and were accompanied by moaning, tachypnea, and oxygen desaturation. Imaging, cerebrospinal fluid, endocrine, metabolic, and genetic screening findings were normal or negative. She was treated with intravenous steroids and immunoglobulins with resolution of symptoms, but she relapsed weeks later. At this time, episodes were more severe. Glycine receptor alpha 1 antibodies were found in serum (titer of 1:200, later 1:320) and cerebrospinal fluid (titer of 1:2). Treatment was restarted with intravenous steroids and immunoglobulins, with major improvement, and she began treatment with oral steroids. She had 4 milder relapses, with improvement after treatment adjustments. CONCLUSIONS AND RELEVANCE To our knowledge, this is the first pediatric case of progressive encephalomyelitis with rigidity and myoclonus associated with glycine receptor alpha 1 antibodies, a potentially severe but treatable antibody-mediated neurological disorder.</description><identifier>ISSN: 2168-6149</identifier><identifier>EISSN: 2168-6157</identifier><identifier>DOI: 10.1001/jamaneurol.2013.1872</identifier><identifier>PMID: 23380884</identifier><language>eng</language><publisher>United States: American Medical Association</publisher><subject>Encephalomyelitis - blood ; Encephalomyelitis - cerebrospinal fluid ; Encephalomyelitis - complications ; Encephalomyelitis - drug therapy ; Female ; Follow-Up Studies ; Humans ; Immunoglobulins - blood ; Immunoglobulins - cerebrospinal fluid ; Immunoglobulins, Intravenous - therapeutic use ; Immunologic Factors - therapeutic use ; Infant ; Muscle Rigidity - blood ; Muscle Rigidity - cerebrospinal fluid ; Muscle Rigidity - complications ; Muscle Rigidity - drug therapy ; Myoclonus - blood ; Myoclonus - cerebrospinal fluid ; Myoclonus - complications ; Myoclonus - drug therapy ; Receptors, Glycine - immunology ; Severity of Illness Index ; Steroids - therapeutic use ; Treatment Outcome</subject><ispartof>JAMA neurology, 2013-04, Vol.70 (4), p.1-4</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://jamanetwork.com/journals/jamaneurology/articlepdf/10.1001/jamaneurol.2013.1872$$EPDF$$P50$$Gama$$H</linktopdf><linktohtml>$$Uhttps://jamanetwork.com/journals/jamaneurology/fullarticle/10.1001/jamaneurol.2013.1872$$EHTML$$P50$$Gama$$H</linktohtml><link.rule.ids>64,314,780,784,3340,27924,27925,76489,76492</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23380884$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Damásio, Joana</creatorcontrib><creatorcontrib>Leite, M. Isabel</creatorcontrib><creatorcontrib>Coutinho, Ester</creatorcontrib><creatorcontrib>Waters, Patrick</creatorcontrib><creatorcontrib>Woodhall, Mark</creatorcontrib><creatorcontrib>Santos, Manuela A</creatorcontrib><creatorcontrib>Carrilho, Inês</creatorcontrib><creatorcontrib>Vincent, Angela</creatorcontrib><title>Progressive Encephalomyelitis With Rigidity and Myoclonus: The First Pediatric Case With Glycine Receptor Antibodies</title><title>JAMA neurology</title><addtitle>JAMA Neurol</addtitle><description>IMPORTANCE Progressive encephalomyelitis with rigidity and myoclonus is characterized by rigidity, painful muscle spasms, hyperekplexia, and brainstem signs. Recently, glycine receptor alpha 1 antibodies have been described in adult patients with progressive encephalomyelitis with rigidity and myoclonus. We describe a pediatric case. OBSERVATIONS A 14-month-old child developed startle-induced episodes of generalized rigidity and myoclonus, axial hyperextension, and trismus, without impairment of consciousness. Episodes occurred during wakefulness and sleep, lasted seconds, and were accompanied by moaning, tachypnea, and oxygen desaturation. Imaging, cerebrospinal fluid, endocrine, metabolic, and genetic screening findings were normal or negative. She was treated with intravenous steroids and immunoglobulins with resolution of symptoms, but she relapsed weeks later. At this time, episodes were more severe. Glycine receptor alpha 1 antibodies were found in serum (titer of 1:200, later 1:320) and cerebrospinal fluid (titer of 1:2). Treatment was restarted with intravenous steroids and immunoglobulins, with major improvement, and she began treatment with oral steroids. She had 4 milder relapses, with improvement after treatment adjustments. CONCLUSIONS AND RELEVANCE To our knowledge, this is the first pediatric case of progressive encephalomyelitis with rigidity and myoclonus associated with glycine receptor alpha 1 antibodies, a potentially severe but treatable antibody-mediated neurological disorder.</description><subject>Encephalomyelitis - blood</subject><subject>Encephalomyelitis - cerebrospinal fluid</subject><subject>Encephalomyelitis - complications</subject><subject>Encephalomyelitis - drug therapy</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Immunoglobulins - blood</subject><subject>Immunoglobulins - cerebrospinal fluid</subject><subject>Immunoglobulins, Intravenous - therapeutic use</subject><subject>Immunologic Factors - therapeutic use</subject><subject>Infant</subject><subject>Muscle Rigidity - blood</subject><subject>Muscle Rigidity - cerebrospinal fluid</subject><subject>Muscle Rigidity - complications</subject><subject>Muscle Rigidity - drug therapy</subject><subject>Myoclonus - blood</subject><subject>Myoclonus - cerebrospinal fluid</subject><subject>Myoclonus - complications</subject><subject>Myoclonus - drug therapy</subject><subject>Receptors, Glycine - immunology</subject><subject>Severity of Illness Index</subject><subject>Steroids - therapeutic use</subject><subject>Treatment Outcome</subject><issn>2168-6149</issn><issn>2168-6157</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkE1LwzAch4MoTua-gIjk6GUzb00zbzI2FRRFJh5L0v7nIm0zk1Totzdjc-aSHJ7nF3gQuqRkQgmhN1-60S103tUTRiifUJWzI3TGqFRjSbP8-PAW0wEahfBF0lGECC5O0YBxrohS4gzFV-8-PYRgfwDP2xI2a127pofaRhvwh41r_GY_bWVjj3Vb4efelbVru3CLl2vAC-tDxK9QWR29LfFMB9hZ93Vf2hbwG6TR6Dy-a6M1rrIQztHJStcBRvt7iN4X8-XsYfz0cv84u3saa5ZncWyoYKUCw3IDmWCK87zUkoDKMp1zs8qzSgkjKBWJ0UYqkkuWDGmkXgHL-BBd73Y33n13EGLR2FBCXad2rgsF5QniVIhpQsUOLb0LwcOq2HjbaN8XlBTb5MV_8mKbvNgmT9rV_ofONFAdpL_ACbjYAcn-n8yklJTzX3F8iR8</recordid><startdate>20130401</startdate><enddate>20130401</enddate><creator>Damásio, Joana</creator><creator>Leite, M. Isabel</creator><creator>Coutinho, Ester</creator><creator>Waters, Patrick</creator><creator>Woodhall, Mark</creator><creator>Santos, Manuela A</creator><creator>Carrilho, Inês</creator><creator>Vincent, Angela</creator><general>American Medical Association</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20130401</creationdate><title>Progressive Encephalomyelitis With Rigidity and Myoclonus: The First Pediatric Case With Glycine Receptor Antibodies</title><author>Damásio, Joana ; Leite, M. Isabel ; Coutinho, Ester ; Waters, Patrick ; Woodhall, Mark ; Santos, Manuela A ; Carrilho, Inês ; Vincent, Angela</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a275t-b142c8eb27be5428337ca60e855a73bf75d84b4114eb2ab6807622c86b6afe253</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Encephalomyelitis - blood</topic><topic>Encephalomyelitis - cerebrospinal fluid</topic><topic>Encephalomyelitis - complications</topic><topic>Encephalomyelitis - drug therapy</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Immunoglobulins - blood</topic><topic>Immunoglobulins - cerebrospinal fluid</topic><topic>Immunoglobulins, Intravenous - therapeutic use</topic><topic>Immunologic Factors - therapeutic use</topic><topic>Infant</topic><topic>Muscle Rigidity - blood</topic><topic>Muscle Rigidity - cerebrospinal fluid</topic><topic>Muscle Rigidity - complications</topic><topic>Muscle Rigidity - drug therapy</topic><topic>Myoclonus - blood</topic><topic>Myoclonus - cerebrospinal fluid</topic><topic>Myoclonus - complications</topic><topic>Myoclonus - drug therapy</topic><topic>Receptors, Glycine - immunology</topic><topic>Severity of Illness Index</topic><topic>Steroids - therapeutic use</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Damásio, Joana</creatorcontrib><creatorcontrib>Leite, M. Isabel</creatorcontrib><creatorcontrib>Coutinho, Ester</creatorcontrib><creatorcontrib>Waters, Patrick</creatorcontrib><creatorcontrib>Woodhall, Mark</creatorcontrib><creatorcontrib>Santos, Manuela A</creatorcontrib><creatorcontrib>Carrilho, Inês</creatorcontrib><creatorcontrib>Vincent, Angela</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>JAMA neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Damásio, Joana</au><au>Leite, M. Isabel</au><au>Coutinho, Ester</au><au>Waters, Patrick</au><au>Woodhall, Mark</au><au>Santos, Manuela A</au><au>Carrilho, Inês</au><au>Vincent, Angela</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Progressive Encephalomyelitis With Rigidity and Myoclonus: The First Pediatric Case With Glycine Receptor Antibodies</atitle><jtitle>JAMA neurology</jtitle><addtitle>JAMA Neurol</addtitle><date>2013-04-01</date><risdate>2013</risdate><volume>70</volume><issue>4</issue><spage>1</spage><epage>4</epage><pages>1-4</pages><issn>2168-6149</issn><eissn>2168-6157</eissn><abstract>IMPORTANCE Progressive encephalomyelitis with rigidity and myoclonus is characterized by rigidity, painful muscle spasms, hyperekplexia, and brainstem signs. Recently, glycine receptor alpha 1 antibodies have been described in adult patients with progressive encephalomyelitis with rigidity and myoclonus. We describe a pediatric case. OBSERVATIONS A 14-month-old child developed startle-induced episodes of generalized rigidity and myoclonus, axial hyperextension, and trismus, without impairment of consciousness. Episodes occurred during wakefulness and sleep, lasted seconds, and were accompanied by moaning, tachypnea, and oxygen desaturation. Imaging, cerebrospinal fluid, endocrine, metabolic, and genetic screening findings were normal or negative. She was treated with intravenous steroids and immunoglobulins with resolution of symptoms, but she relapsed weeks later. At this time, episodes were more severe. Glycine receptor alpha 1 antibodies were found in serum (titer of 1:200, later 1:320) and cerebrospinal fluid (titer of 1:2). Treatment was restarted with intravenous steroids and immunoglobulins, with major improvement, and she began treatment with oral steroids. She had 4 milder relapses, with improvement after treatment adjustments. CONCLUSIONS AND RELEVANCE To our knowledge, this is the first pediatric case of progressive encephalomyelitis with rigidity and myoclonus associated with glycine receptor alpha 1 antibodies, a potentially severe but treatable antibody-mediated neurological disorder.</abstract><cop>United States</cop><pub>American Medical Association</pub><pmid>23380884</pmid><doi>10.1001/jamaneurol.2013.1872</doi><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2168-6149 |
ispartof | JAMA neurology, 2013-04, Vol.70 (4), p.1-4 |
issn | 2168-6149 2168-6157 |
language | eng |
recordid | cdi_proquest_miscellaneous_1325331449 |
source | MEDLINE; American Medical Association Journals |
subjects | Encephalomyelitis - blood Encephalomyelitis - cerebrospinal fluid Encephalomyelitis - complications Encephalomyelitis - drug therapy Female Follow-Up Studies Humans Immunoglobulins - blood Immunoglobulins - cerebrospinal fluid Immunoglobulins, Intravenous - therapeutic use Immunologic Factors - therapeutic use Infant Muscle Rigidity - blood Muscle Rigidity - cerebrospinal fluid Muscle Rigidity - complications Muscle Rigidity - drug therapy Myoclonus - blood Myoclonus - cerebrospinal fluid Myoclonus - complications Myoclonus - drug therapy Receptors, Glycine - immunology Severity of Illness Index Steroids - therapeutic use Treatment Outcome |
title | Progressive Encephalomyelitis With Rigidity and Myoclonus: The First Pediatric Case With Glycine Receptor Antibodies |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T07%3A10%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Progressive%20Encephalomyelitis%20With%20Rigidity%20and%20Myoclonus:%20The%20First%20Pediatric%20Case%20With%20Glycine%20Receptor%20Antibodies&rft.jtitle=JAMA%20neurology&rft.au=Dam%C3%A1sio,%20Joana&rft.date=2013-04-01&rft.volume=70&rft.issue=4&rft.spage=1&rft.epage=4&rft.pages=1-4&rft.issn=2168-6149&rft.eissn=2168-6157&rft_id=info:doi/10.1001/jamaneurol.2013.1872&rft_dat=%3Cproquest_cross%3E1325331449%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1325331449&rft_id=info:pmid/23380884&rft_ama_id=1566613&rfr_iscdi=true |